New Foundation of Hope for Relapsed Refractory Hodgkin Lymphoma Patients
Renowned MD Anderson expert, Dr. Anas Younes gives an update on several breakthrough therapies and strategies for patients living with relapsed refractory Hodgkin lymphoma. Dr. Younes speaks about frontline therapies, regimen combinations and the potential for improved remission rates. He gives patients who have benefited from old drugs hope for the potential to benefit from newer drugs and combination strategies.
Experts & Guests
Anas Younes, M.D.
Professor of Lymphoma/Myeloma, MD Anderson Cancer CenterDr. Anas Younes is Professor and Director of the Clinical and Translational Research Program in the Department of Lymphoma/Myeloma, Division of Cancer Medicine at M. D. Anderson Cancer Center in Houston, Texas. He completed his medical degree at the The University of Damascus School of Medicine followed by postgraduate training at Memorial Sloan-Kettering Cancer Center, The State University of New... more >